| Literature DB >> 34591125 |
Chunhui Yang1, Minjun Ding1, Guiqiang Shao2, Shengjie Jia1, Xue Yin1, Yuhui Cui1, Zetian Wang1, Chunrong Wu3.
Abstract
The present study aimed to explore the potential mechanism of the effect of hyperbaric oxygenation (HBO) preconditioning on cerebral ischemia and reperfusion injury (CIRI). GSE23160 dataset was used to identify differentially expressed genes (DEGs) from striatum between the middle cerebral artery occlusion (MCAO)/reperfusion and sham rats. The gene clusters with continuous increase and decrease were identified by soft clustering analysis in Mfuzz, and functional enrichment analysis of these genes was performed using clusterProfiler package. The intersection set of the genes with significantly altered expression at post-reperfusion 2, 8, and 24 h were screened in comparison to 0 h (sham group), and the expression of these genes was detected in the MCAO/reperfusion model and HBO preconditioning groups by real-time PCR (RT-PCR) and western blotting. A total of 41 upregulated DEGs, and 7 downregulated DEGs were detected, among which the expression of Gpr84 and Ggta1 was significantly upregulated at each reperfusion phase as compared to the sham group, while the expression of Kcnk3 was significantly downregulated except in the postreperfusion 8 h in the striatum group. RT-PCR and western blotting analyses showed that the expression of Ggta1, Gpr84, and Kcnk3 genes between the MCAO/reperfusion and sham rats were consistent with the bioinformatics analysis. In addition, the HBO preconditioning reduced the expression of Ggta1 and Gpr84 and increased the expression of Kcnk3 in MCAO/reperfusion rats. Kcnk3, Ggta1, and Gpr84 may play a major role in HBO-mediated protection of the brain against CIRI.Entities:
Keywords: Cerebral ischemia and reperfusion injury; Ggta1; Gpr84; Hyperbaric oxygenation preconditioning; Kcnk3; Middle cerebral artery occlusion/reperfusion
Mesh:
Year: 2021 PMID: 34591125 PMCID: PMC8599220 DOI: 10.1007/s00221-021-06220-7
Source DB: PubMed Journal: Exp Brain Res ISSN: 0014-4819 Impact factor: 1.972
The primer sequence for each validated gene
| Primer name | Primer sequence (5′-3′) |
|---|---|
| GAPDH-rF | AGACAGCCGCATCTTCTTGT |
| GAPDH-rR | CTTGCCGTGGGTAGAGTCAT |
| Ggta1p-rF | ACCGATTCTGCTGAAGACCT |
| Ggta1p-rR | CAAACAGCAGAGCAACCGAG |
| Gpr84-rF | TTCGGACTCCTCCTCTTTACT |
| Gpr84-rR | ACAACTGGCACCAAGACATAA |
| Kcnk3-rF | GCTCCTTCTACTTCGCCATCA |
| Kcnk3-rR | TGACTAGTGTGAGCGGGATG |
The number of differentially expressed genes identified in each group at different ischemia/reperfusion times
| Cortex | Striatum | |||||
|---|---|---|---|---|---|---|
| 2 h | 8 h | 24 h | 2 h | 8 h | 24 h | |
| Up | 392 | 509 | 815 | 325 | 538 | 899 |
| Down | 281 | 401 | 599 | 265 | 524 | 697 |
| all | 673 | 910 | 1414 | 590 | 1062 | 1596 |
Fig. 1Hierarchical cluster map of DEGs identified in the cortex (A) and striatum (B) groups. The horizontal axis denotes samples, and the right vertical axis shows clusters of DEGs. The smoothly changed color from blue to red encodes expression values from low to high
Fig. 2Eight clusters identified in the cortex group based on gene expression changes of DEGs in the cortex at post-reperfusion 0, 2, 8, and 24 h by soft cluster analysis. Yellow or green colored curves correspond to genes with low membership values, while curves in red or purple correspond to genes with high membership values. If genes have a high membership values for a cluster, they are generally similar to each other and contribute significantly to overall expression trends of one cluster. Using this color scheme, clusters with a large core of tightly co-regulated genescan be easily distinguished from week or noisy clusters
Fig. 3Eight clusters identified in the striatum group based on gene expression changes of DEGs in the striatum at post-reperfusion 0, 2, 8, and 24 h by soft cluster analysis. Curves in yellow or green denote genes with small membership values, while curves in red or purple correspond to genes with big membership values
The results of soft clustering analysis for differentially expressed genes identified in each group
| Cortex | Striatum | |||||
|---|---|---|---|---|---|---|
| Clusters | Gene counts | Total | Clusters | Clusters | Total | |
| Up | Cluster 2 | 93 | 246 | Cluster 4 | 106 | 274 |
| Cluster 4 | 49 | Cluster 6 | 42 | |||
| Cluster 7 | 104 | Cluster 8 | 126 | |||
| Down | Cluster 5 | 75 | 134 | Cluster 2 | 98 | 137 |
| Cluster 6 | 59 | Cluster 7 | 39 | |||
The top five enriched Go terms for continuous up-regulated and down-regulated genes identified in each group listed by p.adjust value
| Category | Term | Description | Count | Gene symbol | p.adjust |
|---|---|---|---|---|---|
| Up-regulated genes in Cortex group | GO:0,002,237 | Response to molecule of bacterial origin | 23 | Ccl12, Ccl5, Cd14, Cd84, Cebpb, Cxcl16, Il1b, Il6, Lbp, Nos3 | 1.22E-11 |
| GO:0,032,496 | Response to lipopolysaccharide | 22 | Nos3, Nr1h3, Nradd, Pycard, Slc11a1, Slpi, Ticam2, Tirap, Tnfrsf1a, Tnfrsf22 | 1.95E-11 | |
| GO:0,050,900 | Leukocyte migration | 21 | Ecm1, Fcer1g, Fcgr3, Hsd3b7, Icam1, Mmp14, Mmp9, Msn, Pycard, Tirap | 4.44E-11 | |
| GO:0,001,819 | Positive regulation of cytokine production | 23 | Bcl3, C3, Ccl2, Ccl5, Cd14, Clec5a, Fcer1g, Tirap, Tlr1, Tnfrsf1a | 4.63E-11 | |
| GO:0,002,685 | Regulation of leukocyte migration | 16 | Anxa1, Ccl12, Ccl2, Ecm1, Icam1, Il1b, Lbp, Mmp14, Mmp9,, Tirap | 4.37E-10 | |
| Down-regulated genes in Cortex group | GO:0,007,611 | Learning or memory | 12 | Drd2, Fgf13, Grin2b, Htr2a, Jph4, Musk, Nf1, Nog, Pak7, Pde1b | 7.86E-07 |
| GO:0,007,613 | Memory | 9 | Cnr1, Cpeb3, Drd2, Fgf13, Grin2b, Htr2a, Musk, Nog, Pak7 | 8.97E-07 | |
| GO:0,050,890 | Cognition | 12 | Drd2, Fgf13, Grin2b, Htr2a, Jph4, Musk, Nf1, Nog, Pak7, Pde1b | 8.97E-07 | |
| GO:0,044,708 | Single-organism behavior | 13 | Alk, Cnr1, Grin2b, Htr2a, Jph4, Musk, Nf1, Nog, Pak7, Pde1b | 3.11E-05 | |
| GO:0,098,662 | Inorganic cation transmembrane transport | 13 | Cacng7, Cacng8, Drd2, Htr2a, Kcnd2, Kcnh3, Kcnk3, Pcsk9, Scn4b | 3.30E-05 | |
Up-regulated genes in Striatum group | GO:0,031,589 | Cell-substrate adhesion | 15 | Jam3, Msln, Myo1g, Notch1, Otoa, Plau, S100a10, Sdc4, Spp1, Tnn | 2.69E-05 |
| GO:0,007,160 | Cell–matrix adhesion | 11 | Col3a1, Gpm6b, Iqgap1, Jam3, Msln, Otoa, Plau, S100a10, Sdc4, Tnn | 0.000111 | |
| GO:0,009,611 | Response to wounding | 16 | Hspb1, Lcp1, Lox, Map2k1, Plau, Pros1, S100a9, Sdc4, Slc11a1, Tnc | 0.000111 | |
| GO:0,050,727 | Regulation of inflammatory response | 13 | C3, Casp1, Ctss, Fcgr2b, Mefv, Myd88, Nr1d2, S100a8, S100a9, Tlr3 | 0.000111 | |
| GO:0,001,525 | Angiogenesis | 16 | Esm1, Hmox1, Hspb1, Hspb6, Ihh, Jam3, Lif, Lrg1, Notch1, Thbs2 | 0.000111 |
Note: GO Gene ontology
The top five enriched pathways for continuous up-regulated and down-regulated genes identified in each group listed by p.adjust value
| Category | Term | Description | Count | Gene symbol | p.adjust |
|---|---|---|---|---|---|
| Up-regulated genes in Cortex group | mmu04668 | TNF signaling pathway | 12 | Bcl3, Ccl12, Ccl2, Ccl5, Cebpb, Icam1, Il1b, Il6, Mlkl, Mmp14, Mmp9, Tnfrsf1a | 1.07E-05 |
| mmu05144 | Malaria | 8 | Ccl12, Ccl2, Hba-a1, Hbb-b1, Icam1, Il1b, Il6, Selp | 4.80E-05 | |
| mmu05133 | Pertussis | 9 | C1qb, C3, C4b, Cd14, Il1b, Il6, Pycard, Ticam2, Tirap | 9.08E-05 | |
| mmu05152 | Tuberculosis | 13 | C3, Cd14, Cebpb, Fcer1g, Fcgr1, Fcgr3, Il1b, Il6, Lbp, Lsp1, Tirap, Tlr1, Tnfrsf1 | 0.000101 | |
| mmu05150 | Staphylococcus aureus infection | 7 | C1qb, C3, C4b, Fcgr1, Fcgr3, Icam1, Selp | 0.000337 | |
| Down-regulated genes in Cortex group | mmu04024 | cAMP signaling pathway | 8 | Atp2b1, Atp2b4, Drd2, Gria3, Grin2b, Htr1d, Rock2, Sstr2 | 0.00716 |
| mmu05033 | Nicotine addiction | 4 | Gabrg1, Gria3, Grin2b, Slc17a8 | 0.009442 | |
| mmu04020 | Calcium signaling pathway | 7 | Atp2b1, Atp2b4, Htr2a, Mylk2, Pde1b, Plcz1, Ryr1 | 0.010304 | |
| mmu05032 | Morphine addiction | 5 | Gabrg1, Gnb4, Pde10a, Pde1b, Pde7b | 0.012376 | |
| mmu04261 | Adrenergic signaling in cardiomyocytes | 6 | Atp2b1, Atp2b4, Cacna2d1, Cacng7, Cacng8, Scn4b | 0.012376 | |
| Up-regulated genes in Striatum group | mmu04512 | ECM-receptor interaction | 6 | Col1a1, Sdc4, Spp1, Thbs2, Tnc, Tnn | 0.025936 |
| mmu05205 | Proteoglycans in cancer | 9 | Col1a1, Ihh, Iqgap1, Map2k1, Msn, Plau, Plaur, Rras2, Sdc4 | 0.025936 |
Fig. 4The Venn diagram of overlapped upregulated genes and shared downregulated genes in both cortex and striatum groups, respectively. A total of 41 overlapped upregulated DEGs and 7 overlapped downregulated DEGs were identified in both groups
Fig. 5The expression trends of Ggta1 (A), Gpr84 (B), and Kcnk3 (C) at 2, 8, and 24 h post-reperfusion identified in both cortex and striatum groups. The expression of Ggta1 and Gpr84 was upregulated with prolonged post-reperfusion time, while Kcnk3 presented downregulation prolonged post-reperfusion time except for post-reperfusion 8 h in the striatum group
Fig. 6The relative expression of key genes. The mRNA levels of Ggta1, Gpr84, and Kcnk3 (A) detected by real-time PCR. The protein levels of Gpr84 and Kcnk3 measured by western blotting. MCAO middle cerebral artery occlusion, HBO hyperbaric oxygenation. *, **, and *** represent P < 0.05, P < 0.01, and P < 0.001 vs. sham operation group, respectively. #, ##, and ### represent P < 0.05, P < 0.01, and P < 0.001 vs. MCAO/reperfusion group, respectively